Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Mark A. Kay, Catherine Scott Manno, Margaret V. Ragni et al. · Nature Genetics · 2000
Cited by 1,022 works. doi:10.1038/73464
Authors
- Mark A. Kay
- Catherine Scott Manno
- Margaret V. Ragni
- Peter J. Larson
- Linda B. Couto
- Alan McClelland
- Bertil E. Glader
- Ah Keng Chew
- Shing Jen Tai
- Roland W. Herzog
- Valder R. Arruda
- Ciaran D. Scallan
- Erik D. Skarsgard
- Alan W. Flake
- Katherine A. High
References
- Experiments in molecular genetics
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)
- Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
- Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
- Haemophilia prophylaxis in young patients–a long‐term follow‐up
- Guidelines for Research Involving Recombinant DNA Molecules
- Adeno-associated virus vectors can be efficiently produced without helper virus
- Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
- Successful expression of human factor IX following repeat administration of adenoviral vector in mice.